Member Info for Ghia

DubleD - every time Richard has done an interview it has been precise and factual. He has signposted clearly here when the news will come.

You know I know the market knows news is not until July so why would this rocket off the back of an interview.

Conversely ODX have stated their intention to manufacture a test developed by others. No one knows when this might happen so the market is second guessing. The CEO does a live news piece and is not careful with his words the market reacts. He is then forced into releasing a corrective statement gains are lost and credibility with it. The real question is why did it take an entire trading day to release the corrective statement that’s the part that stinks!

Here they come!

Nolupus - Yes but only a small punt on the split news.

Jakman59 - Thank you, you are absolutely correct.

Dave - Indeed it is perfect example of buy on rumour sell on news.

Dave - ODX is plummeting as we speak

As suspected ODX rose on hot air could be a painful fall

Haha No worries.

Does ODX have exclusive distribution deals for the tests being developed? and are they global?

Ok thanks I guess IG are over exposed on SNG

Was that through IG? I've been trying all day but can only place an order to close on SNG currently :(

ShareSting - Surely you enjoyed Nolupus’s well thought out ramp earlier though?

Early COPD reading being driven by due diligence from a potential partners in the wings.

Nolupus - Same page here I think, partner waiting in the wings to accelerate this into P3 as part of a licensing deal.

They want COPD data to decide if they want the license for the drug as a whole or just specific to treatment.

Nolupus - This section?

“Over the coming months we will have three major clinical trial read-outs for SNG001, our wholly-owned, inhaled IFN-beta asset: COPD patients with regular seasonal viruses; COVID-19 hospital-treated patients; and the early treatment of COVID-19 patients in the home setting. The Company is active on many fronts from designing and managing novel trials to developing the regulatory strategy and supply chain for potential demand in the future."

Supports your theory for readout order:

1. COPD
2. Hospital
3. Home

“Regulatory Strategy and Supply Chain for potential demand in the future”

It’s a nice statement that. The COPD readout must be part of that regulatory strategy.

Nolupus - Embrace the positivity!!

You are right though it’s always worth trying to see both sides, which is why you are a very valuable contributor to the board even if you do pose some very vague questions sometimes.

There is nothing obviously negative about reading COPD early definitely something pushing this decision.

Almost as if one or several interested parties want to see as much data as possible so they can accurately value what’s on offer...

Nolupus - Are you implying that they will plan to launch a larger Phase 3 Trial which rather than targeting COPD or Covid 19 could encompass a wide range of viral ailments?

Hence reading COPD data at the same time as Covid data would back up the design of the phase 3 trial?

Nolupus - Unfortunately we can only speculate as to the reasonings.

Initially they had hoped to adjust the COPD trial to allow COVID patients with COPD to take part but this never got amended.

Perhaps during the process of applying to amend the trial they where given the opportunity to do an interim analysis which they had not thought would be on the table?

Nolupus - Thanks I was not aware of that fact.

Nolupus - I hope you are correct on COPD results in June that would probably catch out a few COViD speculators that have jumped ship temporarily to chase gains elsewhere before returning.

I can’t see any motive to open COPD early other than that the opportunity presented itself so why not. With both trials in full swing there is probably a window of opportunity to do data analysis without delaying COVID further. 2-3weeks to analyse COPD whilst the hospital trial completes.

Nolupus - Did they specifically say COPD first?

I read:

C19 - July
COPD - Summer
At Home - Hopefully summer dependant on speed of recruitment